Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,233 total articles
OCANF shows bullish technicals: price trading above the 10/20/50-day moving averages, an RSI under 70, and a bullish MACD. Short interest has collapsed from multi-million share levels to ~318k shares with days-to-cover at 7.6, setting up a measured long where a short squeeze can amplify gains. Entry $36.77, stop $32.50, target $45.00 for a mid-term…
TXO Partners (TXO) trades near $12 with a 16%+ distribution yield, a low debt-to-equity ratio of 0.37 and an EV/EBITDA of ~10.6. This trade idea targets a mid-term re-rate into the low-teens/teens driven by yield-hungry buyers and improving operational headlines. Entry $11.98, stop $10.30, target $15.00, horizon: mid term (45 trading days).
InfuSystem (INFU) is a cash-generative provider of home infusion and device services trading at about $8.00. Modest growth, improving margins and a sensible balance sheet make it a reasonable mid-term long trade if regulatory clarity or reimbursement tailwinds materialize. Entry $7.95, stop $7.20, target $10.50 over ~45 trading days.
Viemed Healthcare is trading at reasonable multiples versus its cash-flow profile and operating momentum. The combination of a modest enterprise value, positive free cash flow and an improving patient and revenue backdrop supports a mid-term long trade with a well-defined entry, stop and target.
Cadence (CDNS) remains a clear beneficiary of the AI-driven demand for simulation, verification and semiconductor IP, yet today’s pullback after a sharp run leaves valuation stretched. We lay out a mid-term swing trade that leans long into the company’s secular momentum while protecting capital with a tight stop.
Shift4 Payments has a credible growth narrative and healthy free cash flow, but elevated short interest, weakening technical momentum, and meaningful leverage make it an attractive candidate for a mid-term short. This trade targets a breakdown to $45.00 from an entry at $59.00 with a stop at $68.00 over a 45-trading-day horizon.
Monster Beverage (MNST) is the dominant pure-play energy drink franchise with strong margins, roughly $2.0B in free cash flow and no net debt. The stock trades at a premium - P/E ~46 and EV/EBITDA ~32 - which already prices in continued growth. This trade idea recommends a cautious long entry on controlled weakness with a mid-term target that leave…
Civeo (CVEO) trades at roughly $25 with a market cap near $290M, EV/EBITDA ~6.7 and price-to-sales ~0.46. Negative EPS masks an asset-light lodging business that generates predictable cash flow when mining and energy activity cycles up. A thoughtful buyback program and a compressed valuation argue for a re-rating. This trade idea outlines an entry …
Micron ripped higher after CEO Sanjay Mehrotra said demand is outpacing supply through 2027 and the company is prioritizing enterprise memory (HBM/SSD) over consumer DRAM. Fundamentals - including healthy free cash flow, low leverage, and a dramatic 12-month recovery from a $61 low - support a momentum trade. This piece lays out an actionable entry…
LendingClub plunged ~10% intraday after an earnings beat on 01/29/2026 despite giving stronger-than-consensus 2026 guidance. The move looks driven by short-term disappointment over an accounting shift rather than fundamentals. With a market cap under $2.0B, low PB, and double-digit originations guidance from investor day, this is a tactical long (s…
Micron is trading near all-time highs after a dramatic recovery from 2025 lows. Strong AI-driven memory demand, improving margins, and healthy cash flow support the move. The technicals show bullish momentum; the trade below lays out a mid-term plan with entry, stop and target while flagging the key risks that could derail the rally.
Vistra (VST) combines solid free cash flow, a growing role in AI/tech power contracts, and near-term nuclear upside. The stock looks poised for further gains from 2026 catalysts, but stretched multiples and operational risks mean better risk/reward opportunities may exist elsewhere. This trade plan offers a disciplined entry at $163.00, a $190 targ…
General Dynamics (GD) is pullbacking into technical support after recent strength; fundamentals and defense-market tailwinds support a mid-term swing trade. Entry $350, target $380, stop $335 — a pragmatic play targeting upside above the January highs while limiting downside risk.
Unicycive (UNCY) is a speculative buy ahead of an expected NDA resubmission and renewed FDA inspection focus. The company trades at a sub-$200M market cap with clear binary catalysts, a compact share float, and signs of improving technical momentum. This trade plan targets a mid-term recovery while acknowledging elevated regulatory and legal risk.
Amazon ($AMZN) trades at $242.44 with a $2.58T market cap, a 34x P/E and healthy ROE near 21%. I argue the combination of improving AWS margins, structural ad revenue growth, AI-driven productization across retail and cloud, plus Project Kuiper optionality support a long trade. Entry $242.44, stop $220, target $300 over a 180-trading-day horizon.
Southern Copper (SCCO) remains a high-quality way to play an ongoing copper upswing, backed by strong returns on capital and healthy free cash flow. But the stock is extended: RSI north of 80, a fresh 52-week high at $218.81, and elevated P/E and P/B multiples leave room for sharp mean reversion. My trade plan: hold core positions, consider adding …
Public Storage (PSA) is in a measured slowdown, but strong cash generation, a near-5% yield and a historically resilient business make the current pullback a structured buying opportunity. This trade lays out an entry at $277.45, a stop at $260.00 and a target of $310.00 over a long-term (180 trading days) horizon.
ASE Technology (ASX) is a market leader in IC packaging and testing positioned to benefit from accelerating AI, HPC, and 5G demand. Technical momentum and improving short interest underpin a tactical long entry at $19.55 with a $24.00 long-term target (180 trading days) and a $17.00 stop. The valuation is premium (PE ~39) but justified if ASE captu…
FuboTV is trading near $2.27 with an enterprise value below $900M despite recent integration with Hulu+ Live TV and Disney support. The market appears to be overlooking immediate FCF and scale synergies; this trade idea buys into a re-rate while protecting capital with a tight stop.
Motorcar Parts of America has posted top-line gains and free cash flow, yet earnings have been erratic and the stock trades near technical support after a volatile year. We lay out a mid-term (45 trading days) short trade: entry $12.85, target $9.50, stop $14.00. The thesis rests on stretched operating consistency, mixed guidance, and an expensive …
Meta's stock ripped higher after an earnings beat and bullish guidance. Fundamentals - strong free cash flow, high ROE, low leverage - justify an upgrade. Technicals show momentum but near-term overbought readings argue for a disciplined entry. Trade plan: enter on weakness, stop tight, target a measured breakout above the prior 52-week high.
GlobalFoundries is shifting from a cyclical foundry play to a longer-cycle infrastructure bet. Recent M&A, partnerships in silicon photonics, and favorable policy/tariff tailwinds make the stock a tactical long with defined risk controls. Market cap sits near $24.3B and technical momentum supports an entry around current levels; we set a conservati…
Ameriprise (AMP) looks like a fundamentally cheap, cash-generating wealth manager that has been punished more than its fundamentals justify amid rate volatility. With EPS north of $39, FCF of about $5.9B and a market cap near $48.5B, the stock trades at a mid-teens multiple while technicals show constructive support. Trade plan: enter at $522.45, t…
Sibanye-Stillwater (SBSW) pulled back intraday to $19.30 but remains technically constructive and sits well-positioned to benefit from a multi-year platinum/rhodium supply deficit. This trade idea outlines an actionable entry at $19.60, a stop at $18.00 and a target of $24.00 over a mid-term window (~45 trading days), balancing upside from metal fu…
Travere Therapeutics (TVTX) is trading in a tight range around $31.59 with low-to-moderate volume. Market pricing appears to understate the value of a potential Filspari approval for FSGS. This trade targets a material re-rating on positive regulatory news while keeping a disciplined stop to limit downside if the binary outcome goes the other way.
